AntriaBio

AntriaBio

AntriaBio

AntriaBio is developing proprietary products in sustained release injectable formulations including AB101, a once-a-week basal insulin. $ANTB
Type
B2b
Founded
2010
Raised
$44.4M
Follow us
Alexa global traffic share
Twitter followers
17 Jul 2017
$13,000,000
Post-IPO equity
Medici Investment, Ildong Pharmaceutical, Aju Pharma

Pharmaceutical firm in Louisville raises $13 million

BizWest
21 Mar 2016
$4,350,000
Venture capital (Series A)

SEC FORM D

sec
+1
16 Apr 2015
$2,000,000
Venture capital
14 Apr 2014
$7,296,453
Venture capital
14 Jan 2014
$1,420,000
Debt financing
14 Jan 2013
$825,000
Debt financing
16 Aug 2012
$1,825,000
Debt financing